I have been following Achillion Pharmaceuticals (NASDAQ:ACHN) since October, 2012. My first article (click here) was an in-depth look at the company and the exciting developments of their drug pipeline, to treat, and potentially cure, Hepatitis C.
The stock has bounced around since that first article, and the movement has been rather interesting, but certainly not unusual in the small cap bio-tech world.
The stock was highest when I first wrote about it, and with subsequent follow up articles as well. As you can see from this chart, the most recent upward move has coincided with the recent presentations that the company has made during the month of May.
I outlined these presentation dates in this...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|